Related Experiment Video
Updated: Jul 30, 2026
08:26
Live Imaging of Drug Responses in the Tumor Microenvironment in Mouse Models of Breast Cancer
Published on: March 24, 2013
Imaging cell death in vivo
F Blankenberg1, C Mari, H W Strauss
1Department of Radiology, Stanford University School of Medicine, Stanford, CA, USA.
The Quarterly Journal of Nuclear Medicine : Official Publication of the Italian Association of Nuclear Medicine (AIMN) [And] the International Association of Radiopharmacology (IAR)
|February 20, 2004
Summary
Imaging programmed cell death, or apoptosis, is crucial for clinical care and drug development. Current methods like radiolabeled annexin V show promise, but further research is needed to understand their in vivo mechanisms.
Area of Science:
- Biomedical imaging
- Molecular imaging
- Cellular biology
Background:
- Apoptosis imaging is vital for clinical care and drug development.
- Radiolabeled annexin V is a key agent for in vivo apoptosis studies, currently in clinical trials.
- The precise in vivo uptake mechanisms of annexin V require further investigation.
Purpose of the Study:
- To review current and developing techniques for imaging programmed cell death (apoptosis).
- To discuss the potential applications of apoptosis imaging in various medical conditions.
- To highlight the need for further research into the mechanisms of apoptosis imaging agents.
Main Methods:
- Review of existing literature on apoptosis imaging agents and technologies.
- Discussion of radiolabeled annexin V and its clinical status.
- Exploration of emerging agents like radiolabeled Z-VAD.fmk and advanced MRI techniques.
Main Results:
- Annexin V is extensively studied but its in vivo mechanism is unclear.
- Other agents and technologies like Z-VAD.fmk and MRI are under development.
- Apoptosis imaging has potential applications in cancer, ischemia, and inflammatory diseases.
Conclusions:
- Effective imaging of apoptosis is essential for advancing medical diagnostics and therapeutics.
- Continued research into imaging agents and mechanisms will enhance clinical utility.
- Apoptosis imaging holds significant promise for monitoring treatment response and disease progression.
